Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

We know our long-hauler's study is 13 weeks (91 da

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154081
(Total Views: 595)
Posted On: 03/02/2021 3:23:36 PM
Posted By: kabonk
Re: CDiddy #80448
We know our long-hauler's study is 13 weeks (91 days), with screening, treatment, and follow-up periods. Assessments are through 56 days / 8 weeks.

https://clinicaltrials.gov/ct2/show/NCT04678830

I would guess our study has an 8 week treatment period, 1 week screening, and 4 for follow-up, but that remains to be seen. I would guess we give 2x 350 mg doses once per week for 8 weeks. LL cost would be ~$1500/week = $12K?

Some of the feedback from BP's twitter feed are that:

Drs. Patterson, Yo, et al. (covidlonghaulers.com, youtube video last week, recent BP tweets) say they have 80+ providers, and have treated 500+ patients so far. BP says it isn't a clinical trial. However, he also says he is planning a "treatment" paper to go with the diagnostic paper for long-haulers / PASC. He says 85%+ "improve" on some combination of ivermectin, low dose steroids, and maraviroc. Some of the people being treated have said their treatment was $800 out of pocket for one week, but that some of their symptoms returned after just one week of treatment.

We won't know anything until we see some reports of outcomes for PASC. Hopefully FDA has finalized the endpoints they want to see, and we will be starting our trial soon.

The main problem with LL for PASC is that there is no way to use it off-label since it isn't approved for anything yet. Trial will take a while.




(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us